New Score Models for Predicting Bleeding and Ischemic of Ticagrelor Therapy in Patients with Diabetes Mellitus.
Xiaotong XiaShu ChenChang CaoYanRong YeYun ShenPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2024)
DS-VASc score. This new risk assessment model can potentially detect patients who are at high risk for bleeding and ischemic events. For high-risk patients, the dose of ticagrelor can be adjusted appropriately or the medication can be adjusted.(2023-09-11, ChiCTR2300075627).
Keyphrases
- end stage renal disease
- risk assessment
- ejection fraction
- newly diagnosed
- chronic kidney disease
- acute coronary syndrome
- atrial fibrillation
- peritoneal dialysis
- percutaneous coronary intervention
- healthcare
- prognostic factors
- type diabetes
- coronary artery disease
- metabolic syndrome
- ischemia reperfusion injury
- climate change
- skeletal muscle
- st elevation myocardial infarction
- heavy metals
- glycemic control